Cabezon, M., Malinverni, R., Bargay, J., Xicoy, B., Marce, S., Garrido, A., . . . Zamora, L. (2021). Different methylation signatures at diagnosis in patients with high-risk myelodysplastic syndromes and secondary acute myeloid leukemia predict azacitidine response and longer survival.
Citação norma ChicagoCabezon, M., et al. Different Methylation Signatures At Diagnosis in Patients With High-risk Myelodysplastic Syndromes and Secondary Acute Myeloid Leukemia Predict Azacitidine Response and Longer Survival. 2021.
Citação norma MLACabezon, M., et al. Different Methylation Signatures At Diagnosis in Patients With High-risk Myelodysplastic Syndromes and Secondary Acute Myeloid Leukemia Predict Azacitidine Response and Longer Survival. 2021.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.